Assignee profile:

Genta Incorporated

City:

Berkeley Heights, New Jersey

Country:

United States

Published Applications:

14

Last publication date:

2012-09-27

Patent Grants:

10

Last grant date:

2014-04-15

Top Inventors for applications by Genta Incorporated

These are the the leading inventors for applications assigned to Genta Incorporated:

Recent patent applications by Genta Incorporated

Genta Incorporated based in Berkeley Heights, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2012-09-27
US20120245135A1
Human necessities

Gallium Complexes, Pharmaceutical Compositions And Methods Of Use

#2 | 2012-08-30 ✅ Patent 8,697,892 granted on 2014-04-15
US20120220634A1
Chemistry; metallurgy

Taxane compounds, compositions and methods

#3 | 2012-01-05 ✅ Patent 8,785,669 granted on 2014-07-22
US20120004429A1
Chemistry; metallurgy

Taxane compounds, compositions and methods

#4 | 2010-09-14 ✅ Patent 7,795,232 granted on 2010-09-14
US9709170
-

Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers

#5 | 2010-08-26
US20100216867A1
Chemistry; metallurgy

Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers

#6 | 2009-11-05
US20090275655A1
Human necessities

Pharmaceutical Gallium Compositions and Methods

#7 | 2009-11-05
US20090275654A1
Chemistry; metallurgy

Pharmaceutical Gallium Compositions and Methods

#8 | 2008-07-10 ✅ Patent 7,456,215 granted on 2008-11-25
US20080166296A1
Chemistry; metallurgy

Pharmaceutical gallium compositions and methods

#9 | 2008-07-03 ✅ Patent 7,842,724 granted on 2010-11-30
US20080160103A1
Chemistry; metallurgy

Pharmaceutical gallium compositions and methods

#10 | 2007-08-14 ✅ Patent 7,256,284 granted on 2007-08-14
US10714310
-

Inhibitory oligonucleotides targeted to Bcl-2

#11 | 2007-05-10 ✅ Patent 7,354,952 granted on 2008-04-08
US20070105953A1
Chemistry; metallurgy

Pharmaceutical gallium compositions and methods

#12 | 2006-06-13 ✅ Patent 7,060,690 granted on 2006-06-13
US10053645
-

Methods and compositions for treating a cell-proliferative disorder using CRE decoy oligomers, BCL-2 antisense oligomers, and hybrid oligomers thereof

#13 | 2005-11-24 ✅ Patent 7,119,217 granted on 2006-10-10
US20050261366A1
Chemistry; metallurgy

Tri(alkylcarboxylato)gallium (III) products and pharmaceutical compositions containing them

#14 | 2005-02-10 ✅ Patent 7,855,183 granted on 2010-12-21
US20050032714A1
Chemistry; metallurgy

Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers

AssigneeID:

173573 ⎘